Patent ID: 7153823
Filing Date: 2006-12-26
Classification: A61K,G01N

Abstract:
1. A method for the administration of a therapeutic amount of a growth factor protein formulation in the treatment of a patient displaying symptoms of acute coronary artery disease comprising the steps of: a) administering by inhalation thereby at least one dose of an effective amount of a first therapeutic growth factor protein formulation comprising: b) monitoring one or more clinical indicators of acute coronary artery disease; c) determining, based on monitoring the one or more clinical indicators of coronary artery disease, whether an additional dose of a therapeutic growth factor protein formulation is indicated; d) depending on the results of step c), administering one or more additional doses of a second growth factor protein formulation comprising: e) repeating steps b) through d) until there is a clinical indication of amelioration of the symptoms of acute coronary artery disease in the patient, or until there is a contraindication to continued treatment.